Company Search:
Advanced Search
Sponsored Links
Unum Therapeutics Inc Company Snapshot
Unum Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Unum Therapeutics Inc with three other companies in this sector in the United States: Menlo Therapeutics Inc (2018 sales of $10.64 million of which 100% was operates in one segment), Altimmune Inc ($10.33 million of which 100% was Biodefence Products), and Insmed Incorporated ($9.84 million of which 100% was Pharmaceutical Products).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Unum Therapeutics Inc
  Stock Performance Chart for Unum Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): .74
(Figures in U.S. Dollars)
1 Week 24.7%   13 Weeks -45.5%  
4 Weeks -61.7%   52 Weeks -89.3%  
Unum Therapeutics Inc Key Data:
  Ticker: UMRX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 9,734,000
(Year Ending Jan 2019).
Employees: 56
  Currency: U.S. Dollars Market Cap: 22,552,676
  Fiscal Yr Ends: December Shares Outstanding: 30,663,054
  Share Type: Common Closely Held Shares: 11,963,709
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.